| Andrew Simmelink, | |
|
1350 S Kings Dr Fl 3, Charlotte, NC 28207-2134 | |
| (704) 446-1242 | |
| (704) 446-1241 |
| Full Name | Andrew Simmelink |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 9 Years |
| Location | 1350 S Kings Dr Fl 3, Charlotte, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295120061 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 0101272213 (Virginia) | Primary |
| 207R00000X | Internal Medicine | 209711 (North Carolina) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bon Secours Memorial Regional Medical Center | Mechanicsville, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Richmond Gastroenterology Associates, Inc. | 8426950692 | 28 |
News Archive
A new study shows that an important drug used in the treatment of malignant melanoma has little effect on the melanoma cells themselves. Instead, it activates immune-system cells to fight the disease.
Using a new tool designed to measure a woman's willingness to use a microbicide (topical gels designed to prevent the sexual transmission of HIV), researchers at The Miriam Hospital and Brown University found that women who have used protective methods in the past, and those with casual sexual partners were more willing to use a microbicide compared to their peers.
"The need to ensure that people in Africa have access to essential, high quality, safe and affordable medicines has just received a major boost with the launch of the East African Community (EAC) Medicines Registration Harmonization Project in Arusha, Tanzania, on 30 March 2011," UNAIDS reports in a feature story on its website.
The free fruit scheme in schools, introduced by the UK government in 2004, may confer no long term benefit, says a study in the Journal of Epidemiology and Community Health .
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced the presentation of data from its proof of concept study with lead CNS compound Serdaxin® at the 49th American College of Neuropsychopharmacologists (ACNP) Annual Meeting, held in Miami Beach, FL, December 5-9, 2010 at the Fountainbleau Resort.
› Verified 3 days ago
| Entity Name | Richmond Gastroenterology Associates, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639127962 PECOS PAC ID: 8426950692 Enrollment ID: O20040127000462 |
News Archive
A new study shows that an important drug used in the treatment of malignant melanoma has little effect on the melanoma cells themselves. Instead, it activates immune-system cells to fight the disease.
Using a new tool designed to measure a woman's willingness to use a microbicide (topical gels designed to prevent the sexual transmission of HIV), researchers at The Miriam Hospital and Brown University found that women who have used protective methods in the past, and those with casual sexual partners were more willing to use a microbicide compared to their peers.
"The need to ensure that people in Africa have access to essential, high quality, safe and affordable medicines has just received a major boost with the launch of the East African Community (EAC) Medicines Registration Harmonization Project in Arusha, Tanzania, on 30 March 2011," UNAIDS reports in a feature story on its website.
The free fruit scheme in schools, introduced by the UK government in 2004, may confer no long term benefit, says a study in the Journal of Epidemiology and Community Health .
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced the presentation of data from its proof of concept study with lead CNS compound Serdaxin® at the 49th American College of Neuropsychopharmacologists (ACNP) Annual Meeting, held in Miami Beach, FL, December 5-9, 2010 at the Fountainbleau Resort.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew Simmelink, 165 Wadsworth Dr, North Chesterfield, VA 23236-4500 Ph: (540) 809-6617 | Andrew Simmelink, 1350 S Kings Dr Fl 3, Charlotte, NC 28207-2134 Ph: (704) 446-1242 |
News Archive
A new study shows that an important drug used in the treatment of malignant melanoma has little effect on the melanoma cells themselves. Instead, it activates immune-system cells to fight the disease.
Using a new tool designed to measure a woman's willingness to use a microbicide (topical gels designed to prevent the sexual transmission of HIV), researchers at The Miriam Hospital and Brown University found that women who have used protective methods in the past, and those with casual sexual partners were more willing to use a microbicide compared to their peers.
"The need to ensure that people in Africa have access to essential, high quality, safe and affordable medicines has just received a major boost with the launch of the East African Community (EAC) Medicines Registration Harmonization Project in Arusha, Tanzania, on 30 March 2011," UNAIDS reports in a feature story on its website.
The free fruit scheme in schools, introduced by the UK government in 2004, may confer no long term benefit, says a study in the Journal of Epidemiology and Community Health .
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced the presentation of data from its proof of concept study with lead CNS compound Serdaxin® at the 49th American College of Neuropsychopharmacologists (ACNP) Annual Meeting, held in Miami Beach, FL, December 5-9, 2010 at the Fountainbleau Resort.
› Verified 3 days ago
Dr. Anish Kaushik Vani, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 125 Queens Rd Ste 200, Charlotte, NC 28204 Phone: 704-343-9800 Fax: 704-347-2011 | |
John Michael Fedor, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1237 Harding Pl, Ste 3100, Charlotte, NC 28204 Phone: 704-373-0212 | |
Dr. Michael Warren Smith, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 6115 Park South Dr Ste 100, Charlotte, NC 28210 Phone: 704-554-8787 Fax: 704-554-8774 | |
William Lane Jr., MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 1350 S Kings Dr, Charlotte, NC 28207 Phone: 704-446-4490 | |
Dr. Alagusivakumari Rameshbabu, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 10648 Park Rd, Charlotte, NC 28210 Phone: 704-667-8050 | |
Shibin Thomas Jacob, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 101 E W T Harris Blvd, Bldg 5000 Suite #5101, Charlotte, NC 28262 Phone: 704-863-5847 | |
Oscar Sven Brann, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 6060 Piedmont Row Dr S Fl 10, Charlotte, NC 28287 Phone: 704-489-3094 |